Drugs / ConM SOSIP.v7 gp140
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03961438 Comparator | Nov 2019 → Jun 2022 | HIV infectious disease | Academic Medical Center - University of Amsterdam | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ConM SOSIP.v7 gp140 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03961438 ↗ |
| Modality | Vaccine | “native-like HIV-1 envelope vaccine, ConM SOSIP.v7” NCT03961438 ↗ |
| Route | Intramuscular | “Vaccine administration will be done at months 0, 2 and 6 by intramuscular injection into the deltoid muscle of the non-dominant arm.” NCT03961438 ↗ |